FreeStyle Libre 2 Discharge Trial

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Diabetes Mellitus, Type 2Hypoglycemia
Interventions
DEVICE

FreeStyle Libre 2 CGM

FreeStyle Libre 2 CGM is FDA-approved and will be used according to FDA-approved labeling

DEVICE

FreeStyle Libre Pro blinded CGM

FreeStyle Libre Pro blinded CGM is FDA-approved and will be used according to FDA-approved labeling

DEVICE

FreeStyle Precision Neo blood glucose meter

FreeStyle Precision Neo blood glucose meter is FDA-approved and will be used according to FDA-approved labeling

Trial Locations (2)

30322

RECRUITING

Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta

94301

RECRUITING

Palo Alto Medical Foundation Research Institute, Palo Alto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Diabetes Care

INDUSTRY

collaborator

Emory University

OTHER

lead

Palo Alto Medical Foundation

OTHER